Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Sep 16, 2026, 10:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 24 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: Retrospective Review Clear all
Recruiting No phase listed Observational

Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review

NCT04182607
View directory record Official record
Conditions
Transplant, Kidney Diseases
Interventions
kidney transplant
Procedure
Lead sponsor
Methodist Health System
Other
Eligibility
18 Years and older
Enrollment
240 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2025
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Nov 19, 2024 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Transfusion of Whole Blood and Cesarean Delivery: A Retrospective Review

NCT03523780
View directory record Official record
Conditions
Obstetric Labor Complications
Interventions
Not listed
Lead sponsor
University of Texas Southwestern Medical Center
Other
Eligibility
18 Years to 50 Years · Female only
Enrollment
1,500 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2020
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated May 18, 2020 · Synced Sep 16, 2026, 10:00 AM EDT
Withdrawn No phase listed Observational

BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach

NCT02758288
View directory record Official record
Conditions
BK Virus Infection, BK Virus Nephropathy
Interventions
New Protocol - BK viremia or BK virus nephropathy, Standard Protocol - BK viremia or BK virus nephropathy
Other
Lead sponsor
Loma Linda University
Other
Eligibility
18 Years and older
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2022
U.S. locations
1
States / cities
Loma Linda, California
Source: ClinicalTrials.gov public record
Updated Oct 4, 2020 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Retrospective Chart Review Study of Patients Treated With Votiva Device

NCT04437680
View directory record Official record
Conditions
Vulvovaginal Signs and Symptoms
Interventions
Votiva device
Device
Lead sponsor
InMode MD Ltd.
Industry
Eligibility
18 Years and older · Female only
Enrollment
600 participants
Timeline
2020
U.S. locations
2
States / cities
Hilton Head Island, South Carolina • Lubbock, Texas
Source: ClinicalTrials.gov public record
Updated Jan 10, 2022 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping

NCT02161068
View directory record Official record
Conditions
ADPKD
Interventions
Not listed
Lead sponsor
The Rogosin Institute
Other
Eligibility
18 Years and older
Enrollment
79 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2021
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Mar 1, 2022 · Synced Sep 16, 2026, 10:00 AM EDT
Enrolling by invitation No phase listed Observational

A Review of Precice Intramedullary Limb Lengthening (IMLL) System for Limb Lengthening Procedures in Children.

NCT06714110
View directory record Official record
Conditions
Limb Length Discrepancy
Interventions
Intramedullary Limb Lengthening Device, External Fixator Limb Lengthening Device
Device
Lead sponsor
NuVasive
Industry
Eligibility
0 Months to 12 Years
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
1
States / cities
West Palm Beach, Florida
Source: ClinicalTrials.gov public record
Updated Dec 21, 2025 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational Results available

A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung Transplantation

NCT06503770
View directory record Official record
Conditions
Bronchiolitis Obliterans Syndrome
Interventions
Not listed
Lead sponsor
Zambon SpA
Industry
Eligibility
18 Years and older
Enrollment
284 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2025
U.S. locations
3
States / cities
Cleveland, Ohio • Columbus, Ohio • Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Aug 31, 2026 · Synced Sep 16, 2026, 10:00 AM EDT
Terminated No phase listed Observational

Managing Cyanosis Following Bidirectional Glenn Operation

NCT00327886
View directory record Official record
Conditions
Congenital Disorders
Interventions
Not listed
Lead sponsor
Children's Healthcare of Atlanta
Other
Eligibility
Up to 1 Year
Enrollment
150 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006
U.S. locations
1
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Jun 12, 2007 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine

NCT02684045
View directory record Official record
Conditions
Subjects Received MAGNIFUSE in Posterolateral Lumbar Spine
Interventions
Not listed
Lead sponsor
Medtronic Spinal and Biologics
Industry
Eligibility
Not listed
Enrollment
76 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017
U.S. locations
2
States / cities
Peoria, Illinois • Charlottesville, Virginia
Source: ClinicalTrials.gov public record
Updated Aug 20, 2017 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

A Retrospective Review of Malignant Liver Tumors

NCT00728650
View directory record Official record
Conditions
Liver Cancer
Interventions
Not listed
Lead sponsor
University of Oklahoma
Other
Eligibility
20 Years to 90 Years
Enrollment
228 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2003 – 2011
U.S. locations
1
States / cities
Tulsa, Oklahoma
Source: ClinicalTrials.gov public record
Updated Feb 6, 2012 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational Results available

Patient Factors Associated With Fragmentation of Copper Intrauterine Device (IUD) Requiring Hysteroscopic Removal

NCT07351084
View directory record Official record
Conditions
Intrauterine Device Complications, Contraceptive Device Failure, IUD Fragmentation, Retained Intrauterine Device, Female Contraception, Women's Health, Reproductive Health
Interventions
Not listed
Lead sponsor
University of Kansas Medical Center
Other
Eligibility
18 Years to 60 Years · Female only
Enrollment
44 participants
Timeline
2025
U.S. locations
1
States / cities
Kansas City, Kansas
Source: ClinicalTrials.gov public record
Updated Jun 29, 2026 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Initial Experience With the AngioVac Venous Drainage Cannula

NCT02775565
View directory record Official record
Conditions
Heart Disease
Interventions
AngioVac
Device
Lead sponsor
Angiodynamics, Inc.
Industry
Eligibility
Not listed
Enrollment
51 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2017
U.S. locations
5
States / cities
Burbank, California • Los Angeles, California • Fargo, North Dakota + 2 more
Source: ClinicalTrials.gov public record
Updated Dec 7, 2017 · Synced Sep 16, 2026, 10:00 AM EDT
Not listed No phase listed Observational

The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage

NCT01484808
View directory record Official record
Conditions
Prostate Cancer
Interventions
Not listed
Lead sponsor
University Urological Associates Inc.
Other
Eligibility
50 Years to 74 Years · Male only
Enrollment
6,600 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012
U.S. locations
1
States / cities
Providence, Rhode Island
Source: ClinicalTrials.gov public record
Updated Dec 1, 2011 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Retrospective Natural History Study of Infants and Toddlers With LAMA2-CMD

NCT04299321
View directory record Official record
Conditions
Merosin Deficient Congenital Muscular Dystrophy
Interventions
Not listed
Lead sponsor
Prothelia, Inc.
Industry
Eligibility
2 Years to 21 Years
Enrollment
75 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2021
U.S. locations
1
States / cities
Lakewood, California
Source: ClinicalTrials.gov public record
Updated Feb 6, 2022 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Endoscopic Ultrasound Staging of Periampullary Neoplasms: Retrospective

NCT00880633
View directory record Official record
Conditions
Periampullary Neoplasms
Interventions
Not listed
Lead sponsor
Indiana University
Other
Eligibility
Not listed
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2009
U.S. locations
1
States / cities
Indianapolis, Indiana
Source: ClinicalTrials.gov public record
Updated Feb 16, 2011 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Tecfidera Lymphocyte Chart Review

NCT02519413
View directory record Official record
Conditions
Multiple Sclerosis
Interventions
dimethyl fumarate
Drug
Lead sponsor
Biogen
Industry
Eligibility
18 Years and older
Enrollment
483 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2016
U.S. locations
10
States / cities
Homewood, Alabama • Newport Beach, California • Atlanta, Georgia + 6 more
Source: ClinicalTrials.gov public record
Updated Aug 25, 2016 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years

NCT03561168
View directory record Official record
Conditions
Seizures, Development Delay, Anesthetic Neurotoxicity
Interventions
Change in plan of care based on MRI results
Diagnostic Test
Lead sponsor
Baylor College of Medicine
Other
Eligibility
Up to 1095 Days
Enrollment
561 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2018
U.S. locations
1
States / cities
Houston, Texas
Source: ClinicalTrials.gov public record
Updated Jun 18, 2018 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Use of Robotics for Cholecystectomy; Retrospective Review of Outcomes, Set Up and Learning Curves

NCT03059745
View directory record Official record
Conditions
Cholecystitis, Cholelithiasis
Interventions
Cholecystectomy
Procedure
Lead sponsor
University of California, Davis
Other
Eligibility
18 Years to 65 Years
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2004 – 2017
U.S. locations
2
States / cities
Sacramento, California
Source: ClinicalTrials.gov public record
Updated Jun 10, 2019 · Synced Sep 16, 2026, 10:00 AM EDT
Terminated No phase listed Observational Accepts healthy volunteers

Pre-post Spinal Popliteal Block

NCT05354791
View directory record Official record
Conditions
Foot Surgery, Ankle Surgery
Interventions
Not listed
Lead sponsor
Hospital for Special Surgery, New York
Other
Eligibility
Not listed
Enrollment
1,500 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2023
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Apr 30, 2024 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the Early Onset Sepsis Calculator

NCT04513691
View directory record Official record
Conditions
Maternal; Chorioamnionitis, Affecting Fetus, Early-Onset Sepses, Neonatal
Interventions
EOS Calculator
Diagnostic Test
Lead sponsor
Pediatrix
Other
Eligibility
35 Weeks and older
Enrollment
236 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2022
U.S. locations
1
States / cities
Phoenix, Arizona
Source: ClinicalTrials.gov public record
Updated Nov 21, 2022 · Synced Sep 16, 2026, 10:00 AM EDT
Withdrawn No phase listed Observational

A Retrospective Review - Anti-HLA Antibodies

NCT00460824
View directory record Official record
Conditions
Congenital Disorders
Interventions
Not listed
Lead sponsor
Emory University
Other
Eligibility
Up to 18 Years
Healthy volunteers
Healthy volunteers not accepted
Timeline
Started 1988
U.S. locations
1
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Dec 30, 2013 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational Results available

Sculptra Chart Review

NCT05463978
View directory record Official record
Conditions
Non-facial Skin Aesthetic Conditions
Interventions
Sculptra Aesthetic
Device
Lead sponsor
Galderma R&D
Industry
Eligibility
Not listed
Enrollment
498 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022
U.S. locations
8
States / cities
Pasadena, California • San Diego, California • Solana Beach, California + 3 more
Source: ClinicalTrials.gov public record
Updated Jun 11, 2026 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation

NCT04006184
View directory record Official record
Conditions
Varicose Veins, Venous Reflux, Venous Insufficiency
Interventions
Chart review
Other
Lead sponsor
Lake Washington Vascular
Other
Eligibility
18 Years and older
Enrollment
547 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019
U.S. locations
1
States / cities
Bellevue, Washington
Source: ClinicalTrials.gov public record
Updated Oct 2, 2019 · Synced Sep 16, 2026, 10:00 AM EDT
Completed No phase listed Observational

A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery

NCT04975971
View directory record Official record
Conditions
Anterior Chamber Inflammation, Ocular Pain, Corneal Edema, Corneal Defect, Penetrating KeratoPlasty, Nuclear Cataract, Cortical Cataract, Cataract Senile
Interventions
Dextenza 0.4Mg Ophthalmic Insert
Drug
Lead sponsor
Nicole Fram M.D.
Other
Eligibility
18 Years and older
Enrollment
25 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Jul 25, 2021 · Synced Sep 16, 2026, 10:00 AM EDT